Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Retained Earnings (2019 - 2025)

Vivos Therapeutics has reported Retained Earnings over the past 7 years, most recently at -$125.4 million for Q4 2025.

  • Quarterly Retained Earnings fell 20.32% to -$125.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$125.4 million through Dec 2025, down 20.32% year-over-year, with the annual reading at -$125.4 million for FY2025, 20.32% down from the prior year.
  • Retained Earnings was -$125.4 million for Q4 2025 at Vivos Therapeutics, down from -$118.5 million in the prior quarter.
  • Over five years, Retained Earnings peaked at -$38.7 million in Q1 2021 and troughed at -$125.4 million in Q4 2025.
  • The 5-year median for Retained Earnings is -$87.7 million (2023), against an average of -$84.2 million.
  • Year-over-year, Retained Earnings crashed 58.84% in 2022 and then dropped 11.66% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$55.6 million in 2021, then plummeted by 42.87% to -$79.5 million in 2022, then fell by 17.09% to -$93.1 million in 2023, then decreased by 11.97% to -$104.2 million in 2024, then decreased by 20.32% to -$125.4 million in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Retained Earnings are -$125.4 million (Q4 2025), -$118.5 million (Q3 2025), and -$113.1 million (Q2 2025).